Alkermes and Cogent Biosciences Stock See Action From Activist Investors
Sarissa Capital is pushing for change at biopharmaceutical firm Alkermes. Fairmount Funds lifted its investment in Cogent Biosciences.
Edward Lampert Janssen Pharmaceutica Lampert Foundation Exchange Commission Atlas Venture Fund Alkerme June
Source: marketwatch.com